Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Toxicon ; 128: 50-59, 2017 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-28137621

RESUMO

L-amino acid oxidases (LAAOs) are dimeric flavoproteins that catalyze the deamination of L-amino acid to α-keto acid, producing ammonia and hydrogen peroxide. In this study, we report the crystal structure and molecular dynamics simulations of LAAO from the venom of Bothrops atrox (BatroxLAAO). BatroxLAAO presents several biological and pharmacological properties with promising biomedical applications. BatroxLAAO structure contains the highly conserved structural pattern of LAAOs comprising a FAD-binding domain, substrate-binding domain and helical domain, and a dimeric arrangement that can be stabilized by zinc. Also, molecular dynamics results show an asymmetric behavior, and a direct communication between FAD- and substrate-binding domains of counterpart subunits. These findings shed light on the structural role of dimerization to catalytic mechanism of SV-LAAOs.


Assuntos
Bothrops/metabolismo , L-Aminoácido Oxidase/química , Simulação de Dinâmica Molecular , Animais , Peróxido de Hidrogênio , Conformação Proteica , Venenos de Serpentes/química , Especificidade por Substrato , Zinco/metabolismo
2.
Biochem Biophys Res Commun ; 414(3): 487-92, 2011 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-21986535

RESUMO

Dihydroorotate dehydrogenases (DHODHs) are enzymes that catalyze the fourth step of the de novo synthesis of pyrimidine nucleotides. In this reaction, DHODH converts dihydroorotate to orotate, using a flavine mononucleotide as a cofactor. Since the synthesis of nucleotides has different pathways in mammals as compared to parasites, DHODH has gained much attention as a promising target for drug design. Escherichia coli DHODH (EcDHODH) is a family 2 DHODH that interacts with cell membranes in order to promote catalysis. The membrane association is supposedly made via an extension found in the enzyme's N-terminal. In the present work, we used site directed spin labeling (SDSL) to specifically place a magnetic probe at positions 2, 5, 19, and 21 within the N-terminal and thus monitor, by using Electron Spin Resonance (ESR), dynamics and structural changes in this region in the presence of a membrane model system. Overall, our ESR spectra show that the N-terminal indeed binds to membranes and that it experiences a somewhat high flexibility that could be related to the role of this region as a molecular lid controlling the entrance of the enzyme's active site and thus allowing the enzyme to give access to quinones that are dispersed in the membrane and that are necessary for the catalysis.


Assuntos
Escherichia coli/enzimologia , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/química , Catálise , Di-Hidro-Orotato Desidrogenase , Espectroscopia de Ressonância de Spin Eletrônica , Campos Magnéticos , Ácido Orótico/análogos & derivados , Ácido Orótico/química , Estrutura Terciária de Proteína , Marcadores de Spin
3.
Biochem Biophys Res Commun ; 369(3): 812-7, 2008 May 09.
Artigo em Inglês | MEDLINE | ID: mdl-18302934

RESUMO

Trypanosoma cruzi is the etiological agent of Chagas' disease, a pathogenesis that affects millions of people in Latin America. Here, we report the crystal structure of dihydroorotate dehydrogenase (DHODH) from T. cruzi strain Y solved at 2.2A resolution. DHODH is a flavin mononucleotide containing enzyme, which catalyses the oxidation of l-dihydroorotate to orotate, the fourth step and only redox reaction in the de novo biosynthesis of pyrimidine nucleotides. Genetic studies have shown that DHODH is essential for T. cruzi survival, validating the idea that this enzyme can be considered an attractive target for the development of antichagasic drugs. In our work, a detailed analysis of T. cruzi DHODH crystal structure has allowed us to suggest potential sites to be further exploited for the design of highly specific inhibitors through the technology of structure-based drug design.


Assuntos
Oxirredutases atuantes sobre Doadores de Grupo CH-CH/química , Proteínas de Protozoários/química , Trypanosoma cruzi/enzimologia , Sequência de Aminoácidos , Animais , Antiprotozoários/química , Antiprotozoários/farmacologia , Cristalografia por Raios X , Di-Hidro-Orotato Desidrogenase , Desenho de Fármacos , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Humanos , Dados de Sequência Molecular , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/antagonistas & inibidores , Conformação Proteica , Proteínas de Protozoários/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA